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Introduction {#sec001}
============

General characteristics of bacterial intracellular pathogens, such as *Brucellae*, *Listeriae*, *Salmonellae*, and *Francisellae*, include their adhesion to, internalization into, and proliferation within professional phagocytes. Macrophages are considered to be the preferred target. In addition to infecting professional phagocytes, however, intracellular bacteria also attack non-phagocytic cells. *Brucellae*, for example, are able to invade a broad range of mammalian cell lines \[[@pone.0132571.ref001]--[@pone.0132571.ref003]\] as well as non-phagocytic cells *in vivo*, including erythrocytes \[[@pone.0132571.ref004]\]. *Salmonella* enters the spectrum of non-phagocytic eukaryotic cells using the so-called "trigger" mechanism induced by a specialized secretory apparatus--the Type III secretion system (for review, see \[[@pone.0132571.ref005]\]). *Listeria monocytogenes*, using proteins InlA and InlB, which interact with cellular E-cadherin (an adhesion protein) and Met (also known as hepatocyte growth factor \[HGF\] receptor), respectively, generally activates a zipper-like mechanism for entry into the eukaryotic cell (for review, see \[[@pone.0132571.ref006]--[@pone.0132571.ref009]\].

*Francisella tularensis*, the causative agent of tularemia, is a facultative intracellular pathogen causing zoonotic disease in a wide variety of species, ranging from protozoa to vertebrates, including humans \[[@pone.0132571.ref010]--[@pone.0132571.ref012]\]. An intracellular pathogen with transient extracellular phase \[[@pone.0132571.ref013]\], it dominantly infects and proliferates inside phagocytic cell types both *in vitro* and *in vivo* \[[@pone.0132571.ref014]--[@pone.0132571.ref017]\]. Like other intracellular pathogens, *Francisellae* can be found also within non-phagocytic cells. Lung macrophages and dendritic cells as well as lung endothelial cells and structural alveolar type II epithelial cells are infected in the course of the pneumonic form of tularemia \[[@pone.0132571.ref018]\]. *Francisella* uptake has been documented in hepatocyte cell lines \[[@pone.0132571.ref019]\], fibroblasts, various epithelial cell lines, endothelial cells \[[@pone.0132571.ref020]\], and even erythrocytes \[[@pone.0132571.ref021]\].

In general, the first steps in the bacterial cell invasion process are recognition of the host cell and the bacteria's attachment to it. As the recognition of *Francisellae* by TLR2 is a critical point in the host's protective response \[[@pone.0132571.ref022],[@pone.0132571.ref023]\], attachment is a critical element in the process of bacteria internalization. *Francisella* exposes several proteins at the outer membrane that probably ensure close interaction of the bacterium with the host cell. There is evidence that type IV pili \[[@pone.0132571.ref024]\], *Francisella* outer membrane protein FsaP \[[@pone.0132571.ref025]\], or *Francisella* elongation factor-Tu \[[@pone.0132571.ref026]\] ensure adherence of the bacterium to a host cell under nonopsonic conditions. Under opsonic conditions, the "bridges"between cell membranes ensure the presence of opsonins, as are for example components of a complete serum or surfactants, which effectively mediate the internalization of *Francisellae* into host cells.

Internalization alone from the side of the host cell can be mediated by different cell surface receptors depending upon the conditions under which the process is occurring. Actin rearrangement and active microtubules finalize the internalization process \[[@pone.0132571.ref027],[@pone.0132571.ref028]\]. Uptake of nonopsonized bacteria by macrophages seems to be mediated dominantly by the mannose receptor \[[@pone.0132571.ref029]\]. The complement receptors (CRs) CR1/2, CR3, and CR4 as well as macrophage scavenger receptor class A have been shown, under specific conditions, to participate in the uptake of complete serum-opsonized *F*. *tularensis* into the various professional phagocytes. *Francisellae* opsonized by antibodies are almost exclusively internalized through ligation of Fc receptors (for review, see \[[@pone.0132571.ref012]\]). Moreover, the opsonization of *Francisellae* and their redirection from the mannose receptor to Fc receptors and CRs lead to substantial modulation of intracellular trafficking and the final fate of bacteria inside the phagocyte. Opsonophagocytic receptors alter the intracellular fate of *Francisella* by delivering bacteria through phagocytic pathways that restrict phagosomal escape and intracellular proliferation \[[@pone.0132571.ref030]\].

Recently, we documented that *Francisella* infect *in vitro* murine and human B cell lines and *in vivo* murine peritoneal as well as spleen B cells \[[@pone.0132571.ref031],[@pone.0132571.ref032]\]. Both human and mice B cells have been shown to bind various species of bacteria, including such intracellular bacteria as *Brucella* \[[@pone.0132571.ref033],[@pone.0132571.ref034]\], *Mycobacterium tuberculosis* \[[@pone.0132571.ref035]\], and *Chlamydia trachomatis* \[[@pone.0132571.ref036]\]. Internalization into B cells of one of the *Brucella* subtypes, *Brucella abortus*, recently was shown to be promoted by functional microfilaments. Once inside the B cell, the *Brucella* resides in a late-endosomal/lysosomal compartment \[[@pone.0132571.ref037]\]. Similarly, *Salmonella enterica* serovar Typhimurium invades B cells. The living niche there is the *Salmonella*-containing vacuole (SCV), which can be characterized as a late-endosomal/lysosomal compartment \[[@pone.0132571.ref038]\]. The invasion of *Salmonella* into B cells is an active process controlled by SPI-1, which induces ruffling of the B cell surface membrane that is followed by macropinocytosis of the bacteria and creation of the spacious SCV \[[@pone.0132571.ref039]\]. There is evidence that B cell receptor (BCR) is engaged in the uptake of *Salmonellae* into B cells. BCR-mediated internalization of *Salmonellae* into B cells significantly modulates the fate of the bacterium inside the B cell as well as the fate of the B cell itself. *Salmonella* exists inside B cells in a non-replicative state. The infected B cells undergo differentiation instead of apoptosis, and they secrete anti-*Salmonella* antibodies \[[@pone.0132571.ref040],[@pone.0132571.ref041]\].

Here, we demonstrate that *Francisella tularensis* subsp. *holarctica* strain LVS (FSC155) significantly infects subtypes of murine peritoneal B cells early after intraperitoneal infection. The uptake of *Francisella* into B cells is mediated by the BCR and CRs.

Materials and Methods {#sec002}
=====================

Bacteria and growth conditions {#sec003}
------------------------------

*Francisella tularensis* LVS (FSC155), live vaccine strain, and *F*. *tularensis* LVS/GPF expressing green fluorescent protein (bacteria were kindly provided by Åke Forsberg, FOI, Umea, Sweden), *F*. *tularensis DsbA* mutant \[[@pone.0132571.ref042]\], and *F*. *tularensis iglC* mutant \[[@pone.0132571.ref043]\] were used for the study. All *F*. *tularensis* strains were cultured on McLeod agar enriched with bovine hemoglobin (Becton Dickinson, San Jose, California, USA) and IsoVitalex (Becton Dickinson) at 36.8°C for 24 h. Following incubation, bacterial colonies were lifted from the plates and resuspended in phosphate buffered saline (PBS) such that the optical density was 1.00 (corresponding to bacterial 5 x 10^9^ CFU/mL). The actual number of bacteria in the suspension utilized for the experiments was determined by serial dilutions (10^−6^ and 10^−7^) and the number of colony-forming units (CFU) was calculated.

Animals {#sec004}
-------

Female specific pathogen-free BALB/c mice were purchased from Velaz (Unetice, CZ) and were used at 6--8 weeks of age. Mice were placed in sterile cages with an air-conditioner and stabilized temperature 22 ± 2°C. A 12 h light and 12 h dark regime was used. *In vivo* experiments on mice were conducted under supervision of the institution's Animal Unit and were approved by the Animal Care and Use Committee of the Faculty of Military Health Sciences, University of Defense, Hradec Kralove, Czech Republic under project number 4/10.

Cell suspension {#sec005}
---------------

The mouse B cell line A20 (ATCC TIB-208, Manassas, Virginia, USA), derived from BALB/cAnN mice, and peritoneal cells from BALB/c mice were used. Cell suspensions were resuspended in DMEM cultivation medium supplemented with 10% fetal bovine serum and incubated at 36.8°C in a 5% CO~2~ atmosphere.

Opsonization of bacteria {#sec006}
------------------------

The volume of 500 μL of murine fresh serum or 500 μL of murine heat-inactivated anti-*F*. *tularensis* serum (hereinafter referred to as "antibodies") were added to 4 x 10^9^ bacteria, incubated at 36.8°C for 1 h, washed twice by pre-warmed PBS, resuspended in 1 mL saline, and used for the experiments. Sera diluted to subagglutinating titer were added to 1 mL of bacterial suspension. Heat-inactivated murine fresh serum was used as a control.

Infection of cells {#sec007}
------------------

A20 cells or peritoneal cells (5 x 10^5^ per well) were co-cultivated with unopsonized or opsonized *F*. *tularensis* LVS, *F*. *tularensis* LVS/GFP, or *F*. *tularensis* mutants, in total volume of 0.5 mL per well at multiplicity of infection (MOI) 500. Control A20 cells or peritoneal cells were cultivated without infection. After 3 h incubation at 36.8°C in 5% CO2 atmosphere, cultures were washed using PBS. The proportion of infected cells with *F*. *tularensis* LVS/GFP was examined using flow cytometry. *F*. *tularensis* was stained using rabbit anti-*F*. *tularensis* serum as a primary antibody and goat anti-rabbit antibody conjugated with Alexa Fluor 488 (Becton Dickinson, San Jose, California, USA) as a secondary antibody for fluorescent microscopy. DAPI (Invitrogen, Molecular Probes, Oregon, USA) was used to visualize the nuclei.

Serum preparation {#sec008}
-----------------

### Mouse serum {#sec009}

Anti*-F*. *tularensis* serum was obtained by suspending heat-killed *F*. *tularensis* LVS cells in complete Freund's adjuvant at a concentration of 10^7^ bacteria/mL. The suspension was used for repeating *s*.*c*. immunization of mice. The serum was harvested 21 d after last immunization dose. The titer of sera was determined using enzyme-linked immunosorbent assay (ELISA).

### Rabbit serum {#sec010}

Purified immune high-titer anti-*F*. *tularensis* rabbit sera were obtained by repeated immunization of rabbits. The first dose was 10^6^ *F*. *tularensis* LVS in Freund's adjuvant, the second was administered 3 weeks later with 10^8^ *F*. *tularensis* LVS in saline, and the last immunization was done 5 weeks after the first with dose 10^8^ *F*. *tularensis* LVS in saline. Blood was collected two weeks after the final immunization, serum was purified by ammonium sulphate, and ELISA titer was determined.

Autolysate of *F*. *tularensis* colonies was used for ELISA as antigen coated to flat-bottomed microtiter plates. The reciprocal value of two-fold serial dilution of serum (originally diluted 1 to 10) was used to define a serum titer. Corpuscular, heat-inactivated *F*. *tularensis* antigen was used for determination of agglutinating titer.

Viability of bacteria inside the B cells {#sec011}
----------------------------------------

BALB/c mice were infected with unopsonized *F*. *tularensis* LVS/GFP. After 24 h, peritoneal cells were collected, resuspended in DMEM cultivation medium supplemented with 2% fetal bovine serum, then incubated with the antibody CD19^-^Alexa Fluor 647 (rat anti-mouse IgG2a, clone: 6D5; BioLegend, San Diego, California, USA). Peritoneal CD19^+^ GFP^+^ cells were sorted using a BD FACSAria II Cell Sorter. The relative purity of the sorted CD19^+^GFP^+^ cells infected with with nonopsonized bacteria measured by flow cytometry was 100% while the relative purity of the sorted CD19^+^GFP^+^ cells ingested with opsonized bacteria was 99.5%. Sorted CD19^+^ GFP^+^ cells were washed using PBS and lysed with 0.1% sodium deoxycholate after washing. Actual numbers of bacteria were determined by serial dilution (10^0^ and 10^−2^) and the number of CFU was calculated.

B cell subset identification {#sec012}
----------------------------

Peritoneal cells were subjected to flow cytometry analysis using the antibodies CD19-Alexa Fluor 647 (rat anti-mouse IgG2a, clone: 6D5; BioLegend, San Diego, California, USA), CD5-PerCP (rat anti-mouse IgG2a, clone: 53--7.3; BD Pharmingen, San Jose, California, USA), and CD11b-PE (rat anti-mouse IgG2b, clone: M1/70; BD Pharmingen, San Jose, California, USA). Measurement was made using a CyAn ADP flow cytometer (Dako, Glostrup, Denmark). B-1a cells were characterized as CD19^+^CD5^+^CD11b^+^, B-1b cells as CD19^+^CD5^-^CD11b^+^, and B-2 cells as CD19^+^CD5^-^CD11b^-^, using the Cyan ADP flow cytometer and Summit software version 4.3 (Dako, Glostrup, Denmark). Rat IgG2a FITC-conjugated isotype control (Pierce, Thermo Scientific, USA) and rat IgG2b FITC-conjugated isotype control (Pierce, Thermo Scientific, USA) were used as the isotype controls.

Blocking of the receptors {#sec013}
-------------------------

Peritoneal cells from BALB/c mice were washed using cell wash (PBS with 5% gelatin and 10% sodium azide). Cell suspensions were incubated for 30 min with the following purified blocking antibodies: IgM (for blocking BCR; rat anti-mouse, clone: RMM-1; BioLegend, San Diego, California, USA), CD21/CD35 (for blocking CR1/2; rat anti-mouse, clone: 7G6; BD Pharmingen, San Jose, California, USA), CD11b (for blocking CR3; rat anti-mouse, clone: M1/70; BD Pharmingen), CD11c (for blocking CR4; Armenian hamster anti-mouse, clone: N418; BD Pharmingen), and FcγIII/II (CD16/32 for blocking FcR; rat anti-mouse, clone: 2.4G2; BD Pharmingen). To block unspecific binds, cells were treated with normal rat IgG isotype control (RD System, USA) or Armenian hamster IgG isotype control (Pierce, Thermo Scientific, USA) before staining. Cell suspensions were then washed three times with PBS and infected as described.

Membrane rafts disturbance {#sec014}
--------------------------

To reveal the role of the cholesterol-rich membrane domains in internalizing *F*. *tularensis* into peritoneal B cells, cells were treated with 10 μg/mL filipin (Sigma-Aldrich, St. Louis, Missouri, USA) or 10 mM methyl-β-cyclodextrin (Sigma-Aldrich) for 30 min. Finally, flow cytometry was used to enumerate the infected B cell percentage in the cultures.

Intracellular trafficking of *Francisella* inside the B cells {#sec015}
-------------------------------------------------------------

Fluorescence microscopy was used to identify the colocalization of bacteria and endosomal and lysosomal markers. A20 cells, at total volume 0.5 mL (1 x 10^6^ per well), were infected with *F*. *tularensis* LVS at MOI 500. Infected cells were incubated in DMEM in 5% CO~2~ at 37°C for 5, 15 and 30 min, as well as 1 and 2 h, then washed twice in PBS. The suspensions of cells were adhered to microscope slides using cytospin. The cells were fixed with 3.8% formaldehyde for 30 min. After fixation, cells were washed three times in PBS, neutralized by incubation in PBS with 50 mM NH~4~Cl for 10 min, permeabilized by 0.1% Triton X-100 for 5 min, and blocked by 3% bovine serum albumin (BSA) in PBS for 60 min at room temperature.

Staining: cells were incubated for 45 min with the primary antibody against *F*. *tularensis*--purified immune high-titer anti-*F*. *tularensis* rabbit serum (subagglutinating ELISA titer 1:12800) diluted 1:3000 in 3% BSA in PBS and subsequently with secondary antibody goat anti-rabbit Alexa Fluor 488 (Molecular Probes, Grand Island, New York, USA) diluted 1:500 in 3% BSA in PBS. To detect LAMP-1, cells were stained with rat anti-mouse LAMP-1 antibody (Santa Cruz, Dallas, Texas, USA) diluted 1:100 in 3% BSA in PBS and then with secondary antibody donkey anti-rat Alexa Fluor 594 (Molecular Probes) diluted 1:500 in 3% BSA in PBS. Used for staining EEA1 were goat polyclonal anti-mouse EEA1 (Santa Cruz) diluted 1:100 in 3% BSA in PBS as primary antibody and donkey anti-goat Alexa Fluor 594 (Molecular Probes) diluted 1:500 in 3% BSA in PBS as secondary antibody. To detect Cathepsin D, goat polyclonal anti-mouse Cathepsin D (Santa Cruz) diluted 1:200 in 3% BSA in PBS was used as primary antibody and donkey anti-goat Alexa Fluor 594 (Molecular Probes) diluted 1:500 in 3% BSA in PBS as secondary antibody. Cells were incubated with all antibodies for 45 min, washed three times with PBS, then mounted using Mowiol (Sigma-Aldrich). Microscope slides were viewed by fluorescence microscopy on a Nikon Eclipse Ti (Nikon, Tokyo, Japan). Percentages of colocalization were calculated for an average of 200 cross-sectional images per time point.

Statistical analysis {#sec016}
--------------------

We carried out all experiments at least three times, with each sample of an individual cell suspension being cultivated in triplicate. An unpaired Student's two-tailed *t*-test was applied to all measured data to evaluate statistical significance. *P* values \< 0.05 were accepted as significantly different and were denoted by asterisks.

Results {#sec017}
=======

*Francisella tularensis* infects subsets of B cells in vitro {#sec018}
------------------------------------------------------------

To test the conditions under which *F*. *tularensis* LVS is internalized into B cells, the A20 cell line and murine peritoneal cells from naïve as well as immunized BALB/c mice were infected with unopsonized and/or murine fresh serum opsonized or antibody-opsonized *F*. *tularensis* LVS/GFP.

Microscopic inspection of A20 cell cultures infected with *F*. *tularensis* LVS/GFP demonstrated that opsonization of bacteria with murine fresh serum before infection of cultures increased the number of cells with intracellularly localized bacteria ([Fig 1](#pone.0132571.g001){ref-type="fig"}). *F*. *tularensis* opsonized with murine fresh serum infected 6.39% of A20 cells while unopsonized *Francisellae* infected only 3.15% of cells, as measured by flow cytometry. Opsonization with antibodies had a less-pronounced effect ([Fig 2](#pone.0132571.g002){ref-type="fig"}).

![Fluorescent microscopy.\
The representative picture was chosen to show the difference in the numbers of A20 cells infected with **(A)** unopsonized *F*. *tularensis* LVS/GFP bacteria, **(B)** *F*. *tularensis* LVS/GFP opsonized with murine fresh serum, and **(C)** bacteria opsonized with immune sera. A20 cells in total volume 0.5 mL (1 x 10^6^ cells per well) were infected with *F*. *tularensis* LVS/GFP at MOI 500 for 3 h. The cell nuclei were stained with DAPI. Note: The number of infected cells was counted using flow cytometry.](pone.0132571.g001){#pone.0132571.g001}

![*F*. *tularensis* infecting A20 cells *in vitro*.\
Cells from the A20 mouse B cell line (5 x 10^5^ per well in total volume 0.5 mL) were infected by *F*. *tularensis* LVS/GFP (GFP) opsonized with fresh uninactivated serum (GFP+C) from naïve mice and bacteria opsonized with heat-inactivated immune sera (GFP+Ab) at MOI 500. The cultures were then incubated at 36.8°C and 5% CO2 atmosphere for 3 h. Proportion of infected cells was determined by flow cytometry. Error bars indicate SD around the means of samples processed in triplicate. Two-tailed *t*-tests were used to test for significant differencess between GFP and GFP+C and GFP+iC and GFP+Ab (\*\*\* *P* \< 0.001, \*\* *P* \< 0.01). Results shown from one experiment are representative of three independent experiments.](pone.0132571.g002){#pone.0132571.g002}

The number of peritoneal CD19^+^ cells infected with unopsonized *F*. *tularensis* fluctuated around 5% (4.44 ± 0.74%). Opsonization of *F*. *tularensis* with fresh un-inactivated serum from naïve mice almost doubled the number of infected cells in culture (8.22 ± 1.02%). Opsonization of bacteria with antibodies--in contrast to opsonization of bacteria with murine fresh serum had no effect (4.28 ± 0.59%). If individual CD19^+^ cell subsets were monitored, then the B-1a cells (CD19^+^CD5^+^CD11b^+^ cells) comprised the dominant subset infected with *Francisellae*. B-1b (CD19^+^CD5^-^CD11b^+^) and B-2 (CD19^+^CD5^-^CD11b^-^) cells were also infected, but at lower frequency than were B-1a cells. Opsonization of bacteria with murine fresh serum or with antibodies in fact copied their effect demonstrated on the entire CD19^+^ cell population with the exception that in B-2 cells the effect of opsonization with fresh murine serum was insignificant ([Fig 3](#pone.0132571.g003){ref-type="fig"}). Isotype controls were used for IgG2a (CD19, CD5) and for IgG2b (CD11b). Mean fluorescent intensity for untreated peritoneal control cells was 2.69 ± 0.043, for isotype control IgG2a was 3.50 ± 0.158, for CD19+ (isotype IgG2a) was 454.18 ± 31.641 (*t*-test CD19+ vs IsoC IgG2a *P* = 3.58 x 10^−5^), for CD5+ (isotype IgG2a) was 115.07 ± 6.944 (*t*-test CD5+ vs IsoC IgG2a *P* = 2.16 x 10^−5^), for isotype control IgG2b was 3.54 ± 0.106, and for CD11b+ (IgG2b) was 539.18 ± 56.917 (*t*-test CD11b+ vs IsoC IgG2b P = 1.84 x 10^−4^).

![*F*. *tularensis* infecting subsets of B cells *in vitro*.\
Subsets of B cells were infected for 3 h with unopsonized *F*. *tularensis* LVS/GFP (GFP), *F*. *tularensis* LVS/GFP opsonized with fresh un-inactivated serum (GFP+C) from naïve mice, and bacteria opsonized with heat-inactivated immune sera (GFP+Ab). The proportions of infected CD19^+^ cells from all measured cells and of infected B-1a, B-1b, and B-2 cells from CD19^+^ cells were measured by flow cytometry. Error bars indicate SD around the means of samples processed in triplicate. Two-tailed *t*-test was used to test for significant differences between GFP and GFP+C and GFP+Ab (\*\*\* *P* \< 0.001, \*\* *P* \< 0.01, \* *P* \< 0.05). Results shown from one experiment are representative of three independent experiments.](pone.0132571.g003){#pone.0132571.g003}

*Francisella tularensis* strain FSC200 Δ*iglC* and Δ*ftdsbA* deletion mutants failed to enter the A20 cell line {#sec019}
---------------------------------------------------------------------------------------------------------------

Two deletion mutants to *F*. *tularensis* virulence factors IglC and *Francisella* analog to the bacterial DsbA protein (FtdsbA) were used to test the participation of *Francisella* in the internalization process into B cells. The 23 kDa pathogenicity island protein IglC is essential for the survival and proliferation of *F*. *tularensis* in macrophages \[[@pone.0132571.ref044]\]. The FtdsbA protein is a conserved hypothetical lipoprotein with homology to thiol/disulfide oxidoreductase proteins and is essential for *Francisella* invasivity and intracellular survival \[[@pone.0132571.ref042],[@pone.0132571.ref045]\]. Mutants to these significant virulence factors prepared from fully virulent *F*. *tularensis* subsp. *holarctica* strain FCS200 are highly attenuated in virulence for mice in comparison with the original virulent wild strain \[[@pone.0132571.ref042],[@pone.0132571.ref045]\]. Both mutants, as they are attenuated in virulence, are also defective in the ability to enter B cells as demonstrated by fluorescent microscopy. During the first 2 h, only around 1% of A20 cells were infected with these mutants ([Fig 4](#pone.0132571.g004){ref-type="fig"}). Moreover, the number of bacteria inside infected cells did not exceed 1 bacterium per infected cell. Thus, the genes that control infectivity and virulence of *F*. *tularensis* are important also for the entry of bacteria into B cells.

![Deletion mutant *F*. *tularensis* strains failed to enter the A20 cells.\
A20 cells were infected with wild type *F*. *tularensis* FSC200 (FSC200), with deletion mutant *F*. *tularensis* FSC200 Δ*ftdsbA* (FSC200 ΔftdsbA), and with deletion mutant *F*. *tularensis* FSC200 Δ*iglC* (FSC200 ΔiglC), respectively, at MOI 500. The infected cells were determined by florescent microscopy. The cells were stained with DAPI to visualize nuclei and with rabbit anti-*F*. *tularensis sera* and goat anti-rabbit secondary antibody conjugated with Alexa Fluor 488 to visualize *F*. *tularensis*. Error bars indicate SD around the means of samples processed in triplicate. Two-tailed *t*-test was used to test for significant differences between FSC200 and FSC200 ΔftdsbA and FSC200 ΔiglC. (\*\*\* *P* \< 0.001). Results shown from one experiment are representative of three independent experiments.](pone.0132571.g004){#pone.0132571.g004}

Receptor blocking demonstrated the engagement of BCR and CR1/2 {#sec020}
--------------------------------------------------------------

To further analyze the entrance gate for *F*. *tularensis* on B cells, we used the blocking antibodies against BCR, CR1/2, CR3, CR4, and FcγR to eliminate their participation in the process of *Francisella* internalization into this cell type. We tested the effect of BCR blocking on the subsets of peritoneal CD19^+^ cells, recognizing that not all B cell subsets utilize, as a response to interaction with bacterium, their unique BCRs for bacterial entry. The effect of other receptor blocking was monitored only on peritoneal CD19^+^ cells as a whole because there are no data indicating that these receptors are not universal in relation to B cell subsets.

The effect of BCR blocking on CD19^+^ cells in its entirety and on individual B cell subsets demonstrated that the BCR alone under unopsonized conditions is important only for the entry of *F*. *tularensis* into B-1a cells. The remaining two monitored subsets displayed only insignificant differences in the number of infected cells in unblocked and blocked B cell cultures. Moreover, opsonization with fresh murine serum or antibodies had no effect on the basic difference between B-1a cells on the one hand and B-1b and B2 cells on the other ([Fig 5](#pone.0132571.g005){ref-type="fig"}).

![Blocking of BCR receptor.\
Peritoneal cells were incubated with the blocking antibody anti-IgM (BCR). Thereafter, the cells were infected for 3 h with **(A)** unopsonized *F*. *tularensis* LVS/GFP (GFP), **(B)** *F*. *tularensis* LVS/GFP opsonized with complement (GFP+C), and **(C)** *F*. *tularensis* LVS/GFP opsonized with antibodies (GFP+Ab). Entry into CD19^+^ cells (expressed as percentage of infected CD19^+^ from all CD19^+^ cells) and individual B cell subsets (expressed as percentage of infected B-1a from all B-1a cells, infected B-1b from all B-1b cells, and infected B-2 from all B-2 cells) was detected by flow cytometry. Error bars indicate SD around the means of samples processed in triplicate. Two-tailed *t*-test was used to test for significant differences between untreated cells and cells with blocked BCR (\*\*\* *P* \< 0.001, \*\* *P* \< 0.01). Results shown from one experiment are representative of three independent experiments.](pone.0132571.g005){#pone.0132571.g005}

The experiments with the effect of CRs blocking on the entry of fresh murine serum opsonized *Francisella* into CD19^+^ cells revealed that of those CRs tested only blocking of CR1/2 significantly reduced the number of infected CD19^+^ cells in *in vitro* cultures. Blocking of CR3 and CR4 had no significant effect ([Fig 6](#pone.0132571.g006){ref-type="fig"}).

![Blocking of CRs.\
Peritoneal cells were incubated with the antibodies against CD21/CD35 (CR1/2), CD11b (CR3), and CD11c (CR4). After blocking, the cells were infected for 3 h with either *F*. *tularensis* LVS/GFP (GFP) or *F*. *tularensis* LVS/GFP opsonized with complement (GFP+C) and the proportions of infected CD19^+^ cells were detected by flow cytometry. Error bars indicate SD around the means of samples processed in triplicate. Two-tailed *t*-test was used to test for significant differences against GFP. The significance of CR blocking effect was calculated between GFP+C and all groups with blocked CRs (\*\*\* *P* \< 0.001). Results shown from one experiment are representative of three independent experiments.](pone.0132571.g006){#pone.0132571.g006}

The effect of FcγR blocking in experiments with antibody-opsonized *Francisellae* was quite negligible, but repeated experimentation with *Francisellae* opsonized with antibodies and murine fresh serum, representing complement components in their entirety, demonstrated profound decline in the number of infected peritoneal CD19^+^ cells. In subsequent experiments, individual subsets of CD19^+^ cells were monitored. In this case, too, and with the exception of global CD19^+^ cells, only the number of infected B-1a cells was significantly reduced by blocking of FcγR ([Fig 7](#pone.0132571.g007){ref-type="fig"}).

![Blocking of FcγR.\
Peritoneal cells were incubated with the antibody against CD16/32 (dFcRg). Thereafter, cells were infected with *F*. *tularensis* LVS/GFP (GFP), *F*. *tularensis* LVS/GFP opsonized with antibodies (GFP+Ab), and *F*. *tularensis* LVS/GFP opsonized with murine fresh serum and antibodies (dFcRg+GFP+Ab+C) at MOI 500. Entry into all B cells (CD19^+^) and individual B cell subsets was detected 3 h after infection by flow cytometry. Error bars indicate SD around the means of samples processed in triplicate. Two-tailed *t*-test was used to test for significant differences between GFP and GFP+Ab and between GFP+Ab and dFcRg+GFP+Ab+C (\*\*\* *P* \< 0.001, \*\* *P* \< 0.01). Results shown from one experiment are representative of three independent experiments](pone.0132571.g007){#pone.0132571.g007}

Disturbing lipid rafts {#sec021}
----------------------

Lipid rafts are well-conserved membrane microdomains that contain high concentrations of cholesterol, sphingolipids, glycosylphosphatidylinositol, GPI-anchored proteins, and dually acylated proteins with kinase characteristics \[[@pone.0132571.ref046]\]. For disturbing lipid rafts, the cholesterol-binding agent filipin or methyl-beta cyclodextrin (cyclodextrin) was used to evaluate the role of cholesterol-rich membrane domains on internalization of *F*. *tularensis* into peritoneal B cell subsets. Experimental conditions were adjusted so that they could show the effect of opsonization of bacteria with complement, represented here by fresh murine serum, which contributes significantly to infection of B cells by *F*. *tularensis*. Unexpectedly, it was clearly demonstrated that filipin and cyclodextrin inhibited the entry of *F*. *tularensis* into peritoneal CD19^+^ cells only under opsonic conditions. The numbers of cells infected with murine fresh serum opsonized bacteria were reduced by nearly 50% in cultures influenced by cyclodextrin or filipin. Without opsonization, both lipid rafts disturbing agents had only marginal effect on the number of infected CD19^+^ cells. The same insignificant effect was obtained after monitoring individual B cell subsets in cultures infected with nonopsonized bacteria ([Fig 8](#pone.0132571.g008){ref-type="fig"}). Considering this together with the results obtained from the experiments with opsonization of bacteria and receptor blocking, it can be concluded that for effective *Francisella* uptake by B cell subsets, the key element from the side of B cells seems to be coordinated construction of a supramolecular receptor structure in lipid rafts. This conclusion was reached based on the assumption that opsonic conditions are much closer to *in vivo* situations than are experimental nonopsonic conditions *in vitro* or *ex vivo*.

![Disturbance of lipid rafts.\
For disturbing lipid rafts, the cholesterol-binding agent filipin or methyl-beta cyclodextrin (Cyclodex) was used. The peritoneal B cells were pretreated with 10 μg/mL filipin or 10 mM cyclodextrin and consequently infected with **(A)** *F*. *tularensis* LVS/GFP or **(B)** opsonized *F*. *tularensis* LVS/GFP with complement. Entry into all B cells (CD19^+^) and individual B cell subsets was detected by flow cytometry. Error bars indicate SD around the means of samples processed in triplicate. Two-tailed *t*-test was used to test for significant differences between untreated B cells and cyclodextrin- or filipin-treated cells (\*\*\* *P* \< 0.001). Results shown from one experiment are representative of three independent experiments.](pone.0132571.g008){#pone.0132571.g008}

Intracellular trafficking of *Francisella* inside the B cells {#sec022}
-------------------------------------------------------------

Once internalized into B cells, *F*. *tularensis*-containing endosomes associate with early endosome antigen 1 (EEA1) followed by the late endosomal/lysosomal membrane marker LAMP-1, and finally they associate with cathepsin D. The association of *F*. *tularensis* LVS-containing endosomes with EEA1 increased from 25.80 ± 8.81% at 5 min to 37.03 ± 8.86% at 15 min, at which time the association with this early endosomal marker terminated. Co-association of *F*. *tularensis* LVS with LAMP-1 increased from 12.74 ± 3.08% at 5 min to 31.25 ± 4.00% at 30 min. The association with cathepsin D peaked 30 min post infection at 34.07 ± 14.58%, and at 2 h post infection the association with cathepsin D still represented 20.20 ± 6.75% ([Fig 9](#pone.0132571.g009){ref-type="fig"}). Step-by-step association of *F*. *tularensis*-containing vacuoles with early endosomal marker, late endosomal marker, and finally phago/lysosomal marker indicate that these vacuoles follow the endocytic pathway in its complexity.

![Intracellular trafficking.\
A20 mouse B cell line (1 x 10^6^ per well in total volume 0.5 mL) was infected with *F*. *tularensis* LVS (MOI 500). Cells were infected for 5, 15 and 30 min, as well as 1 and 2 h. To identify intracellular trafficking, endosomal/lysosomal membrane markers EEA1, LAMP-1, and Cathepsin D were used for determining colocalization of these markers with *F*. *tularensis* LVS by fluorescent microscopy. Error bars indicate SD around the means of samples obtained from three independent experiments.](pone.0132571.g009){#pone.0132571.g009}

It should be noted that when a microscopic study of *F*. *tularensis*--B cell interaction had been carried out, a minority of intracellularly localized *Francisellae* were not localized in membrane-bound compartments \[[@pone.0132571.ref031]\]. Also in the present case, as can be seen in [Fig 9](#pone.0132571.g009){ref-type="fig"}, fewer than 50% of intracellularly localized *Francisellae* colocalized with the endosomal marker used. Intracellular trafficking of *F*. *tularensis* in B cells thus occurs along the endosomal pathway, but without significant multiplication of bacteria, as previously demonstrated \[[@pone.0132571.ref031]\].

Discussion {#sec023}
==========

The established functional view of B cells assumes that these cells, which are involved in Ag presentation during initiation of the adaptive phase of immune responses against bacteria, extract antigens from the bacterial surface or, alternatively, from the surface of dendritic cells, or they capture the proteins shed or secreted by bacteria. The dominant feature in this process is immunological synapse formation \[[@pone.0132571.ref047],[@pone.0132571.ref048]\]. This standard view was based on the conviction that B cells, as non-phagocytic cells, lack the ability to internalize particulate antigens. Recently, however, there are data showing that bacterial pathogens, including intracellular bacteria, are internalized (or actively enter) into murine as well as human B cells and B cell lines. *Salmonellae* survive inside B cell lines, mouse spleen B cells, B cell precursors, as well as plasma cells in murine bone marrow \[[@pone.0132571.ref038],[@pone.0132571.ref049]\]. *Listeria monocytogenes* can infect virtually all cell types, including primary or transformed B cells \[[@pone.0132571.ref050]\]. B lymphocytes, pre-B cells, and B blasts bind, ingest, and permit multiplication of such pathogens as *Chlamydia trachomatis* \[[@pone.0132571.ref036]\] and *Mycobacterium tuberculosis* \[[@pone.0132571.ref051]\] or opsonized *Brucella abortus* \[[@pone.0132571.ref037]\]. *F*. *tularensis*, another intracellular pathogen, also infects murine primary B cells and murine and human B cell lines, as we have shown previously \[[@pone.0132571.ref031]\]. The entry of intracellular bacteria into B cells or B cell precursors thus seems to be a common phenomenon, albeit one restricted to only a limited part of the B cell population. Typically, only about 5% to 10% of B cells in culture have been documented as infected.

In our experimental setup, the first contact of *Francisella* with the B cell was characterized by the creation of a tight junction between bacterial and eukaryotic cell membranes \[[@pone.0132571.ref031]\]. The area of *Francisella* and B cell mutual contact is microscopically reminiscent of the immunological synapse formation \[[@pone.0132571.ref047]\]. Subsequently, a significant number of CD19^+^ cells engulf *Francisellae*. The increased proportion of infected B cells can be detected under opsonic conditions when fresh murine serum from naïve mice has been used in completing the cultivation medium (see [S1 Table](#pone.0132571.s002){ref-type="supplementary-material"}.). Opsonization with heat-inactivated immune serum, unlike fresh murine serum opsonization, had no significant effect on *Francisella* engulfment by B cells. *Francisellae* localized in intracellular space of B cells did not proliferate but did remain alive. We were able to cultivate bacterial colonies after seeding separated CD19^+^ peritoneal cells onto McLeod plates 24 h after infection (see [S1 Fig](#pone.0132571.s001){ref-type="supplementary-material"}).

Blocking experiments documented BCR and CR1/2 engagement in the process of recognizing and engulfing *Francisella* into B cells under *ex vivo* conditions. The CR3 and CR4 are substantially not involved in these processes. Thus, the receptor profile engaged in the internalization of *Francisellae* demonstrated here, together with the activation markers and co-receptors CD80 and CD86 expression demonstrated in the previous publication \[[@pone.0132571.ref031]\], can ensure, inter alia, optimal immune response of CD19^+^ cells.

According to the data presented here, the BCR utilizes CR1/2 not only for expressing optimal adaptive humoral immune response (for review, see \[[@pone.0132571.ref052]\]) but also for recognition and consequent internalization of bacteria into B cells, which is precisely in accordance with the concept of dual antigen recognition by B cells \[[@pone.0132571.ref052]--[@pone.0132571.ref054]\]. These events are occurring at the periphery, thus suggesting that peripheral B cells are among the active cellular components participating in innate immune responses against bacteria.

To initiate the process of *F*. *tularensis* internalization into CD19^+^ cells under opsonizing conditions, the B cell membrane lipid bilayer must be fluid and contain cholesterol because filipin or cyclodextrin significantly reduces the number of intracellularly localized *Francisellae*. Filipin may form large planar aggregates between the two layers of the membrane. It may be absorbed at the membrane surface, may be located at the upper layer of the membrane, and can form the filipin--sterol complexes within the membrane bilayer. Cyclodextrin enhances cholesterol solubility and thereby causes the instability of cholesterol-enriched lipid rafts \[[@pone.0132571.ref055]\]. Bacteria alone, as multivalent corpuscular antigens, can cluster the BCR and in the presence of complement can span both BCRs and CRs. Moreover, it seems likely that bacteria crosslinking BCRs and CRs orient these into a common membrane domain. Also in this respect, therefore, the process of bacteria internalization into B cells corresponds to the process involved in BCR activation, as well as in antigen capture and processing. In the latter case, BCR signaling requires BCR clustering where the tetraspanin microdomains and/or lipid rafts are involved \[[@pone.0132571.ref056],[@pone.0132571.ref057]\]. Interestingly, when the complement is not involved in the primary mutual interaction of the bacterium with the B cell, the BCR of B cells--minimally of B1a cells--probably specific to bacterial antigens alone, seems sufficient to achieve the signals for internalization of surface-bound bacteria. In our case, during the B cell--*Francisella* primary interaction, the term "specific to bacterial antigen" means not only B cells specific to unique *Francisella* antigens (i.e., so-called hypothetical proteins) but also B cells specific to pan-bacterial markers including pathogen-associated molecular paterns (PAMPs) carried by *Francisella*. In our experience, the sera from naïve SPF mice reacted in western blots with several *F*. *tularensis* proteins that are not unique proteins of *Francisellae*.

Taken together, the initial events seem to constitute a special example of a common antigenic-recognition phenomenon during internalization of intracellular bacteria into B cells. Whether or not the *Francisellae* actively participate in the process of their internalization into this cell type is still unknown. Nevertheless, *F*. *tularensis* strain FSC200 Δ*iglC* and Δ*ftdsbA* deletion mutants are defective in the ability to enter B cells. The *iglC* gene is coded in a highly conserved *Francisella* pathogenicity island (FPI), a region of 16 to 19 protein-coding genes from which a subset of genes share limited homology with core structural components of a Type VI secretion system (T6SS) and which are needed for delivery of virulence factors into host cells \[[@pone.0132571.ref058],[@pone.0132571.ref059]\]. The gene for a conserved hypothetical lipoprotein with homology to thiol/disulfide oxidoreductase proteins, a DsbA homologue, designated also as FipA \[[@pone.0132571.ref060]\], is likely responsible for proper folding of substrates having virulence factor character \[[@pone.0132571.ref042],[@pone.0132571.ref061],[@pone.0132571.ref062]\]. It thus seems likely that if the FPI codes the genes for functional T6SS, then secretion of virulence factors that are substrates of Fip A will be, at minimum, indispensable for successful entry of *F*. *tularensis* into B cells. Whether the role of T6SS and/or FipA consists in transferring the ligands of host receptors in proper conformation to bacterial surface or in modulation of host cell internalization mechanisms remains to be elucidated. Moreover, killed, formaldehyde vapor-treated, *F*. *tularensis* FSC200 does not enter B cells \[[@pone.0132571.ref031]\].

*Francisella* infect only a small, but still significant number of B cells. What factors define the ability to be infected is unclear. When the BCR is engaged, the possibility exists that the criterion for infection may be the specificity of this BCR for the given antigen. Selective infection of antigen-specific B cells by *Salmonella* already has been demonstrated \[[@pone.0132571.ref041]\]. The existence of B cell subsets can be another reason for the uneven ability to engulf bacteria. Peritoneal cavity murine B-1 cells can differentiate into a mononuclear phagocyte *in vitro* and acquire the ability to phagocytize large particles \[[@pone.0132571.ref063]\]. In the *ex vivo* experimental system presented here, all tested subsets of peritoneal B cells, meaning B-1a, B-1b, and B-2 cells, were infected with unequal frequency. This inequality in ability to be infected became more distinct when bacteria were opsonized with murine fresh serum. In this case, B-1b and B-2 cells were more frequently infected than were B-1a cells. Interestingly, only peritoneal B-1a cells were identified to engulf, or to be infected by, *F*. *tularensis* after *in vivo* intraperitoneal infection \[[@pone.0132571.ref032]\]. Thus, the BCRs of B-1a cells alone seem to be sufficient for generation of signals enabling the engulfment of bacteria, and the co-signaling from CR1/2 has only a minimal impact on the functional profile of B-1a cells that interact with bacterium. In contrast to B-1a cells, B-1b and B-2 cells seem to need the cooperation of their BCRs with CR1/2 to generate signals that initiate engulfment of *F*. *tularensis*. Recent studies have shown that B cell subsets of mammalian B cells in general have phagocytic activity. Nevertheless, only a proportion of cells of individual B cell subsets show phagocytic activity to stimulation with particles. Research has shown that 14--17% of B-1a cells, 8.6--11.4% of B-1b cells, and less than 1.5% of B-2 B cells in the peritoneal cavity demonstrated phagocytic activity both *in vitro* and *in vivo* \[[@pone.0132571.ref064],[@pone.0132571.ref065]\]. Whether or not the internalization of *F*. *tularensis* into B-1a cells, on the one hand, and internalization into B-1b or B-2 cells, on the other, is carried out under the same signaling scenario during *in vivo* and *in vitro* studies is recently unclear. On the one hand, this may be macropinocytosis, as has been demonstrated for *Mycobacteriae* and *Salmonellae* \[[@pone.0132571.ref039],[@pone.0132571.ref051]\]. On the other hand, it may be classical opsonophagocytosis as a dominant mechanism for internalization of particles.

In summary, we can conclude that *F*. *tularensis* actively induces entry into B cells. The results presented here suggest that BCRs alone at the B-1a subset can ensure the internalization process. The BCRs on B-1b and B-2 cells need co-signaling from the co-receptor containing the CR1/2 to initiate *F*. *tularensis* engulfment. In this case, the fluidity of the surface cell membrane is a prerequisite for bacteria internalization.

Supporting Information {#sec024}
======================

###### Relative infectivity of *F*. *tularensis* LVS opsonized with fresh murine sera (C) and inactivated fresh murine sera (iC).

The volume of 500 μL of fresh murine sera (C) or 500 μL of murine heat-inactivated fresh sera (iC) as a control were added to 4 x 10^9^ bacteria, incubated at 36.8°C for 1 h, washed twice with pre-warmed PBS, resuspended in 1 mL saline, and used for the experiments. To opsonized bacteria the sera were added to 1 mL of bacterial suspension. A20 cells (5 x 10^5^ per well) were co-cultivated with unopsonized, opsonized with C, and iC resp. *F*. *tularensis* LVS/GFP in total volume of 0.5 mL per well at MOI 500. Control A20 cells were cultivated without infection. After 3 h incubation cultures were washed using PBS at 36.8°C and 5% CO~2~ atmosphere. The proportion of infected cells with *F*. *tularensis* LVS/GFP was examined using flow cytometry. Error bars indicate SD around the means of samples processed in triplicate. Relative infectivity was calculated as a ratio among A20 cells infected with *F*. *tularensis* LVS/GFP and A20 cells infected with opsonized bacteria. Proportional number of infected A20 cells with GFP was laid to be one. Two-tailed *t*-test was used to find significant difference between GFP and GFP+C and, GFP+iC (\* *P* \< 0.05). Results shown from one experiment are representative of three independent experiments. Note: Heat-inactivated sera were prepared by heating sera in water bath (56°C) at the volume of 0.5 mL for 30 min.

(PDF)

###### 

Click here for additional data file.

###### Viability of bacteria inside the B cells.BALB/c mice were infected with *F*. *tularensis* LVS/GFP.

After 24 h peritoneal cells were collected, resuspended in DMEM cultivation medium supplemented with 2% fetal bovine serum and then incubated with the antibody CD19-Alexa Fluor 647. Peritoneal CD19^+^ cells were sorted using BD FACSAria II Cell Sorter. Sorted CD19^+^ cells were washed using PBS and lysed by 0.1% sodium deoxycholate after washing. Actual numbers of bacteria were determined by serial dilutions (10^0^ and 10^−2^) and the number of CFU was calculated. ^1^ Number of CD19^+^ cells seeded onto McLeod plates in volume 50 μL and cultivated at 36.8°C. ^2^ The number of CFU was determined after 48--72 h of cultivation.

(PDF)

###### 

Click here for additional data file.
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